Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies left to report, and Spectrum Pharmaceuticals is ...

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug ...

Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff process and set September 24, 2025 as the deadline for investors to seek appointment as the new lead ...

PHILADELPHIA, Sept. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that an inspection of the ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between May 12, 2022 and September 22, 2022, both dates ...

The US Federal Trade Commission (FTC) cleared the acquisition of Allos by Spectrum Pharma which is expected to close on September 4, 2012. Spectrum Pharma stated that it will accept for payment shares ...

The lawsuit, Christiansen v. Spectrum Pharmaceuticals, Inc., et al., has been ongoing since late 2022 and early 2023. At that time, multiple class actions were filed against the company, alleging that ...

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This ...

SAN FRANCISCO, Sept. 22, 2025 /PRNewswire/ -- A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers ...

SAN FRANCISCO, CA / ACCESS Newswire / August 28, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action, offering a new ...